Advanced search
Publication Cover
Patient Preference and Adherence Volume 17, 2023 - Issue
Submit an article Journal homepage
90
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORT

Feasibility of Electronic Medication Monitoring Among Adolescents and Emerging Adults with Sickle Cell Disease

Aimee K Hildenbrand1 Center for Healthcare Delivery Science, Nemours Children’s Health, Wilmington, DE, USA;2 Division of Behavioral Health, Nemours Children’s Hospital Delaware, Wilmington, DE, USA;3 Department of Pediatrics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0147-3232View further author information
ORCID Icon,
Katherine M Kidwell4 Department of Psychology, Syracuse University, Syracuse, NY, USAView further author information
,
Meghan E McGrady5 Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA;6 Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USAORCID Iconhttps://orcid.org/0000-0002-3150-3239View further author information
ORCID Icon,
Constance A Mara5 Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA;6 Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USAView further author information
,
Charles T Quinn6 Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA;7 Division of Hematology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USAView further author information
&
Lori E Crosby5 Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA;6 Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USAView further author information
Pages 3167-3171 | Received 28 Jul 2023, Accepted 25 Nov 2023, Published online: 04 Dec 2023

References

  • Ballas SK. The evolving pharmacotherapeutic landscape for the treatment of sickle cell disease. Mediterr J Hematol Infect Dis. 2020;12(1):e2020010. doi:10.4084/mjhid.2020.010
  • Arnett JJ. Adolescence and Emerging Adulthood: A Cultural Approach. 3rd ed. Upper Saddle River, NJ: Pearson-Prentice Hall; 2007.
  • Walsh KE, Cutrona SL, Kavanagh PL, et al. Medication adherence among pediatric patients with sickle cell disease: a systematic review. Pediatrics. 2014;134(6):1175–1183. doi:10.1542/peds.2014-0177
  • Loiselle K, Lee JL, Szulczewski L, Drake S, Crosby LE, Pai AL. Systematic and meta-analytic review: medication adherence among pediatric patients with sickle cell disease. J Pediatr Psychol. 2015;41(4):406–418. doi:10.1093/jpepsy/jsv084
  • Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115(17):3447–3452. doi:10.1182/blood-2009-07-233700
  • Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999–2009). Pediatr Blood Cancer. 2013;60(9):1482–1486. doi:10.1002/pbc.24557
  • McGrady ME, Ramsey RR. Using electronic monitoring devices to assess medication adherence: a research methods framework. J Gen Intern Med. 2020;35(9):2707–2714. doi:10.1007/s11606-020-05905-z
  • Berkovitch M, Papadouris D, Shaw D, Onuaha N, Dias C, Olivieri NF. Trying to improve compliance with prophylactic penicillin therapy in children with sickle cell disease. Br J Clin Pharmacol. 1998;45(6):605–607. doi:10.1046/j.1365-2125.1998.00730.x
  • Inoue S, Kodjebacheva G, Scherrer T, et al. Adherence to hydroxyurea medication by children with sickle cell disease (SCD) using an electronic device: a feasibility study. Int J Hematol. 2016;104(2):200–207. doi:10.1007/s12185-016-2027-x
  • Olivieri NF, Vichinsky EP. Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy. J Pediatr Hematol Oncol. 1998;20(1):26–31. doi:10.1097/00043426-199801000-00004
  • Kristman V, Manno M, Côté P. Loss to follow-up in cohort studies: how much is too much? Eur J Epidemiol. 2004;19(8):751–760. doi:10.1023/B:EJEP.0000036568.02655.f8
  • Fewtrell MS, Kennedy K, Singhal A, et al. How much loss to follow-up is acceptable in long-term randomised trials and prospective studies? Arch Dis Child. 2008;93(6):458–461. doi:10.1136/adc.2007.127316
  • Crosby LE, Joffe NE, Peugh J, Ware RE, Britto MT. Pilot of the chronic disease self-management program for adolescents and young adults with sickle cell disease. J Adolesc Health. 2017;60(1):120–123. doi:10.1016/j.jadohealth.2016.08.022
  • McGrady ME, Holbein CE, Smith AW, et al. An independent evaluation of the accuracy and usability of electronic adherence monitoring devices. Ann Intern Med. 2018;169(6):419–422. doi:10.7326/M17-3306
  • Badawy SM, Thompson AA, Liem RI. Technology access and smartphone app preferences for medication adherence in adolescents and young adults with sickle cell disease. Pediatr Blood Cancer. 2016;63(5):848–852. doi:10.1002/pbc.25905

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.